Delivery Order SPE2DB25D3012-SPE2DB25FXACX
- Not listed
- This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,351.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 2, 2023, with a completion date of February 3, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.82 fixed-price contract is for the delivery of 90-count bottles of the generic drug Anastrozole 1 mg Tablets. The contract has a period of performance through March 28, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,157.20 contract is for the delivery of 4,560,051,951 units of Anastrozole 1 mg tablets. The contract has an ultimate completion date of February 27, 2023 and was awarded on February 24, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
- This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA). The $2,377.16 delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Anastrozole 1 mg tablets. The $4,266.59 firm fixed-price contract has a performance period ending on September 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products...
- This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,034.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC...
- This federal contract award, with a ceiling value of $3,526.74, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB20D3505|SPE2DB23FT6G8, is a delivery order for the supply of Anastrozole 1 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,112.34 firm fixed-price delivery order covers the supply of 4561438074 - ANASTROZOLE 1 MG TABLET 90S, with a period of performance through July 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.93 firm fixed-price delivery order is for the supply of Anastrozole 1 mg tablets, a medication used to treat breast cancer. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,175.58 firm fixed-price contract is for the delivery of 4,562,781,280 units of Anastrozole 1 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a $750,000...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXACXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Anastrozole 1 mg tablets in a quantity of 90 units, with a contract ceiling value of $1,898.16. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with the federal procurement system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. This prime contract serves as the overarching vehicle through which the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. The company's federal procurement history demonstrates extensive experience fulfilling medical supply requirements across multiple therapeutic domains, positioning it as a critical vendor for Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/16/25 |